Results 171 to 180 of about 30,090 (224)

Excluding Ascites From the GEMA‐Na Score Does Not Impact Outcome Predictions in Liver Transplant Candidates

open access: yesLiver International, Volume 46, Issue 3, March 2026.
ABSTRACT Background and Aims Although GEMA‐Na outperforms MELD 3.0 for liver allocation, concerns about the subjectivity of its ascites component persist. We compared the performance of a GEMA‐Na iteration that excludes ascites with other allocation scores.
Manuel Luis Rodríguez‐Perálvarez   +32 more
wiley   +1 more source

Exploring the immunomodulatory impacts of blood manufacturing consolidation

open access: yesTransfusion, Volume 66, Issue 3, Page 491-506, March 2026.
Abstract Introduction The immunomodulatory consequences of blood transfusion, known as transfusion‐related immune modulation (TRIM), are often not captured by hemovigilance systems. Changes to blood product manufacturing processes may impact patient outcomes.
Amanda Kauffman   +11 more
wiley   +1 more source

BK polyomavirus-associated progressive multifocal leukoencephalopathy following mogamulizumab therapy for erythrodermic mycosis fungoides. [PDF]

open access: yesFront Cell Infect Microbiol
Longo M   +16 more
europepmc   +1 more source

Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Torkildsen Ø   +3 more
europepmc   +1 more source

Interferon dependent immune memory during HSV-1 neuronal latency via increased H3K9me3 and restriction by ATRX. [PDF]

open access: yesNat Commun
Whitford AL   +7 more
europepmc   +1 more source

Neurological Infections in HIV: A Case-Based Review for Clinicians. [PDF]

open access: yesInfez Med
Gupta N   +8 more
europepmc   +1 more source

Apoptotic vesicles from endothelial cells promote endothelial progenitor cell differentiation and angiogenesis via miR-30a-5p mediated activation of the EGFR/PI3K/AKT/VEGF pathway. [PDF]

open access: yesStem Cell Res Ther
Lei S   +23 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy